BREAKING
Nexxen Q4 FY26 Earnings Results 6 hours ago Daktronics Q3 FY26 Earnings Results 7 hours ago Earnings Summary: SmartRent Returns to Growth in Q4FY25, Achieves Positive EBITDA. 9 hours ago Abercrombie & Fitch Q4 2025 Earnings Results 10 hours ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 1 day ago Best Buy 4Q 2026: Earnings Analysis 1 day ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 2 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 2 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 2 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 5 days ago Nexxen Q4 FY26 Earnings Results 6 hours ago Daktronics Q3 FY26 Earnings Results 7 hours ago Earnings Summary: SmartRent Returns to Growth in Q4FY25, Achieves Positive EBITDA. 9 hours ago Abercrombie & Fitch Q4 2025 Earnings Results 10 hours ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 1 day ago Best Buy 4Q 2026: Earnings Analysis 1 day ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 2 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 2 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 2 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 5 days ago
ADVERTISEMENT
AlphaGraphs

Key highlights from Abbott (ABT) Q3 2022 earnings results

Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales increased 1.3%. Net earnings declined 31.7% to $1.4 billion while EPS fell 30.8% to $0.81. Adjusted EPS dropped 18% to $1.15. For FY2022, Abbott expects adjusted EPS to be $5.17-5.23. Prior performance

$ABT October 19, 2022 1 min read
NYSE
$ABT · Earnings

Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales increased 1.3%. Net earnings declined 31.7% to $1.4 billion while EPS fell 30.8% to $0.81. Adjusted EPS dropped 18% to $1.15. For FY2022, Abbott expects adjusted EPS to be $5.17-5.23. Prior performance

· October 19, 2022

Abbott (NYSE: ABT) reported third quarter 2022 earnings results today.

Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales increased 1.3%.

Net earnings declined 31.7% to $1.4 billion while EPS fell 30.8% to $0.81. Adjusted EPS dropped 18% to $1.15.

For FY2022, Abbott expects adjusted EPS to be $5.17-5.23.

Prior performance

Abbott Laboratories Q2 2022 Earnings Infographic